Literature mining on pharmacokinetics numerical data: a feasibility study
- PMID: 19345282
- PMCID: PMC2737819
- DOI: 10.1016/j.jbi.2009.03.010
Literature mining on pharmacokinetics numerical data: a feasibility study
Abstract
A feasibility study of literature mining is conducted on drug PK parameter numerical data with a sequential mining strategy. Firstly, an entity template library is built to retrieve pharmacokinetics relevant articles. Then a set of tagging and extraction rules are applied to retrieve PK data from the article abstracts. To estimate the PK parameter population-average mean and between-study variance, a linear mixed meta-analysis model and an E-M algorithm are developed to describe the probability distributions of PK parameters. Finally, a cross-validation procedure is developed to ascertain false-positive mining results. Using this approach to mine midazolam (MDZ) PK data, an 88% precision rate and 92% recall rate are achieved, with an F-score=90%. It greatly out-performs a conventional data mining approach (support vector machine), which has an F-score of 68.1%. Further investigate on 7 more drugs reveals comparable performances of our sequential mining approach.
Figures





Similar articles
-
PARM--an efficient algorithm to mine association rules from spatial data.IEEE Trans Syst Man Cybern B Cybern. 2008 Dec;38(6):1513-24. doi: 10.1109/TSMCB.2008.927730. IEEE Trans Syst Man Cybern B Cybern. 2008. PMID: 19022723
-
An integrated pharmacokinetics ontology and corpus for text mining.BMC Bioinformatics. 2013 Feb 1;14:35. doi: 10.1186/1471-2105-14-35. BMC Bioinformatics. 2013. PMID: 23374886 Free PMC article.
-
Drug-drug interaction predictions with PBPK models and optimal multiresponse sampling time designs: application to midazolam and a phase I compound. Part 2: clinical trial results.J Pharmacokinet Pharmacodyn. 2008 Dec;35(6):661-81. doi: 10.1007/s10928-008-9105-5. Epub 2009 Jan 7. J Pharmacokinet Pharmacodyn. 2008. PMID: 19130187 Free PMC article.
-
Methods and tools for mining multivariate temporal data in clinical and biomedical applications.Annu Int Conf IEEE Eng Med Biol Soc. 2009;2009:5629-32. doi: 10.1109/IEMBS.2009.5333788. Annu Int Conf IEEE Eng Med Biol Soc. 2009. PMID: 19964402 Review.
-
[Introduction to medical data mining].Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2003 Sep;20(3):559-62. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2003. PMID: 14565039 Review. Chinese.
Cited by
-
Text mining for drug-drug interaction.Methods Mol Biol. 2014;1159:47-75. doi: 10.1007/978-1-4939-0709-0_4. Methods Mol Biol. 2014. PMID: 24788261 Free PMC article. Review.
-
Data Digitizing: Accurate and Precise Data Extraction for Quantitative Systems Pharmacology and Physiologically-Based Pharmacokinetic Modeling.CPT Pharmacometrics Syst Pharmacol. 2020 Jun;9(6):322-331. doi: 10.1002/psp4.12511. Epub 2020 Jun 16. CPT Pharmacometrics Syst Pharmacol. 2020. PMID: 32543786 Free PMC article. Review.
-
Characterization of the mechanism of drug-drug interactions from PubMed using MeSH terms.PLoS One. 2017 Apr 19;12(4):e0173548. doi: 10.1371/journal.pone.0173548. eCollection 2017. PLoS One. 2017. PMID: 28422961 Free PMC article.
-
Extraction of pharmacokinetic evidence of drug-drug interactions from the literature.PLoS One. 2015 May 11;10(5):e0122199. doi: 10.1371/journal.pone.0122199. eCollection 2015. PLoS One. 2015. PMID: 25961290 Free PMC article.
-
Recent progress in automatically extracting information from the pharmacogenomic literature.Pharmacogenomics. 2010 Oct;11(10):1467-89. doi: 10.2217/pgs.10.136. Pharmacogenomics. 2010. PMID: 21047206 Free PMC article. Review.
References
-
- Woosley RLaCJ. Drug development and the FDA’s critical path initiative. Clinical Pharmacology and Therapeutics. 2007;(81):129–133. - PubMed
-
- Veit M. New strategies for drug development. Berl Munch Tierarztl Wochenschr. (117):276–287. - PubMed
-
- D’Andrea Gea. A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin. Blood. 2005;(105):645–649. - PubMed
-
- Kirchheiner JBJ. Clinical consequences of cytochrome P450 2C9 polymorphisms. Clin Pharmacol Ther. 2005;(77):1–16. - PubMed
-
- Badagnani Iea. Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variants. J Pharmacol Exp Ther. (318):521–529. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources